# Heart Failure With Normal Ejection Fraction (HFNEF) in Hemodialysed Patients: Beneficial Effect of Ivabradine

> **NCT01373619** · PHASE4 · COMPLETED · sponsor: **University of Campania Luigi Vanvitelli** · enrollment: 150 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Ivabradine

## Key facts

- **NCT ID:** NCT01373619
- **Lead sponsor:** University of Campania Luigi Vanvitelli
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2011-01
- **Final completion:** 2012-01
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2012-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01373619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01373619, "Heart Failure With Normal Ejection Fraction (HFNEF) in Hemodialysed Patients: Beneficial Effect of Ivabradine". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01373619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*